PMC:7402624 / 57637-57847 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T483","span":{"begin":49,"end":52},"obj":"Body_part"},{"id":"T484","span":{"begin":71,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A483","pred":"fma_id","subj":"T483","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A484","pred":"fma_id","subj":"T484","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1868","span":{"begin":44,"end":48},"obj":"Gene"},{"id":"1869","span":{"begin":57,"end":60},"obj":"Gene"},{"id":"1870","span":{"begin":65,"end":68},"obj":"Gene"},{"id":"1879","span":{"begin":98,"end":106},"obj":"Species"},{"id":"1880","span":{"begin":195,"end":201},"obj":"Species"},{"id":"1892","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"1893","span":{"begin":147,"end":163},"obj":"Disease"}],"attributes":[{"id":"A1868","pred":"tao:has_database_id","subj":"1868","obj":"Gene:952"},{"id":"A1869","pred":"tao:has_database_id","subj":"1869","obj":"Gene:925"},{"id":"A1870","pred":"tao:has_database_id","subj":"1870","obj":"Gene:920"},{"id":"A1879","pred":"tao:has_database_id","subj":"1879","obj":"Tax:9606"},{"id":"A1880","pred":"tao:has_database_id","subj":"1880","obj":"Tax:9606"},{"id":"A1892","pred":"tao:has_database_id","subj":"1892","obj":"MESH:C000657245"},{"id":"A1893","pred":"tao:has_database_id","subj":"1893","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T396","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"T397","span":{"begin":147,"end":163},"obj":"Disease"}],"attributes":[{"id":"A396","pred":"mondo_id","subj":"T396","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A397","pred":"mondo_id","subj":"T397","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T884","span":{"begin":44,"end":48},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T885","span":{"begin":57,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T886","span":{"begin":65,"end":68},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T887","span":{"begin":69,"end":75},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T888","span":{"begin":195,"end":201},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6337","span":{"begin":53,"end":55},"obj":"Chemical"}],"attributes":[{"id":"A81850","pred":"chebi_id","subj":"T6337","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T114","span":{"begin":147,"end":163},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T336","span":{"begin":0,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}

{"project":"2_test","denotations":[{"id":"32669297-18468462-135105229","span":{"begin":203,"end":205},"obj":"18468462"},{"id":"32669297-29236685-135105229","span":{"begin":203,"end":205},"obj":"29236685"},{"id":"32669297-22286307-135105229","span":{"begin":203,"end":205},"obj":"22286307"}],"text":"Nevertheless, the frequency of the KI67+ or CD38+HLA-DR+ CD8 and CD4 T cell responses in COVID-19 patients was similar in magnitude to other acute viral infections or live attenuated vaccines in humans (47–49)."}